EUDA Health Holdings Limited EUDA
17.86
1.44
8.77%
as of 25 Sep
- Market cap
- $49.2M
- P/E
- 0.0×
Follow EUDA
| Jun '25 | Jun '24 | Dec '23 | Jun '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | — | 0.00 | |
P/FCF ratio |
— | — | — | 0.00 | |
P/Operating CF |
— | — | — | (696.08) | |
P/B ratio |
— | — | — | 0.00 | |
Price to Tangible BV |
— | — | — | 0.00 | |
EV/Sales |
— | — | — | 0.00 | |
EV/EBITDA |
— | — | — | 0.00 | |
EV/Operating CF |
— | — | — | (133.19) | |
EV/FCF |
— | — | — | (133.19) | |
Quick Ratio |
0.12 | 0.08 | — | 0.15 | |
Current Ratio |
0.23 | 0.13 | — | 0.19 | |
Net Debt/EBITDA |
0.00 | 0.00 | — | 0.00 | |
Debt/Assets |
95.67% | 15.37% | 0.00% | 27.24% | |
Debt/Equity |
(0.54) | (0.05) | — | (0.09) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | — | 0.00 | |
Capex/Depreciation |
(0.26) | (0.15) | — | — | |
Research and Development Expense of Revenue |
— | — | — | 1.50% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 200.04% | |
Intangible Assets out of Total Assets |
0.12 | 0.17 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Graham Net Nets |
— | — | — | (0.02) | |
Graham Number |
— | — | — | 4.15 | |
Earnings Yield |
— | — | — | (18.09%) | |
Free Cash Flow Yield |
— | — | — | (0.75%) | |
Revenue per Share |
— | — | — | 0.05 | |
Operating CF per Share |
0.00 | 0.00 | — | 0.00 | |
Capex per Share |
0.00 | 0.00 | — | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | — | 0.00 | |
Cash per Share |
0.00 | 0.00 | — | 0.01 | |
Shareholders Equity per Share |
0.00 | 0.00 | — | (0.28) | |
Interest Debt per Share |
0.00 | 0.00 | — | 0.00 | |
Book value per Share |
0.00 | 0.00 | — | (0.28) | |
Free Cash Flow |
(1.24) | (1.26) | — | — | |
Working Capital |
(4.40) | (6.83) | — | (6.44) | |
Capital Expenditures |
(0.02) | 0.00 | — | — | |
Net Current Asset Value |
(4.54) | (6.98) | — | (6.58) | |
EV/EBIT |
— | — | — | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
— | — | — | (550.96%) | |
Price to Operating Income |
— | — | — | 0.00 | |
| Other line items | |||||
Average Receivables |
1.31 | 2.15 | — | — | |
Average Payables |
0.98 | 1.43 | — | — | |
Average Assets |
13.80 | 1.01 | 43.63 | 44.43 | |
Average Common Equity |
(3.62) | 38.12 | — | 38.03 |
Columns are period end dates